Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Xin H, Zhang C, Ding Z, Zhang M, et al. TACE plus PD-1 inhibitor (Camrelizumab) treatment for bridging to tumor resection in HCC: Case reports. Clin Res Hepatol Gastroenterol 2022;46:101777.
PMID: 34333197


Privacy Policy